Editorial: Neuroprotective mechanisms and translational approaches in the retina

Editorial: Neuroprotective mechanisms and translational approaches in the retina

Bibliographic Details
Main Authors:	Afsun Sahin, Markus Tschopp, Cavit Agca
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Neuroscience
Subjects:	neuroprotection gene therapy CRISPR-Cas9 hypoxia retinal metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1140759/full

Similar Items

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial
by: Halit Yusuf Altay, et al.
Published: (2022-10-01)

Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
by: Radwa Ewaisha, et al.
Published: (2023-02-01)

CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
by: Emir Begagić, et al.
Published: (2024-01-01)

Gene editing and therapy – A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019-07-01)

High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs
by: Laura Siles, et al.
Published: (2023-02-01)

Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
by: Andrew McDonald, et al.
Published: (2024-03-01)

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
by: Bashdar Mahmud Hussen, et al.
Published: (2023-07-01)

Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders
by: Daniel Allen, et al.
Published: (2023-04-01)

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
by: Wei Sheng Siew, et al.
Published: (2021-08-01)

CRISPR/Cas patents and health-related publications in South America
by: LARIANE FRÂNCIO, et al.
Published: (2023-06-01)

Effects of editing DFR genes on flowers, leaves, and roots of tobacco
by: Jiarui Jiang, et al.
Published: (2023-07-01)

The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease
by: Luis A. Martinez Velazquez, et al.
Published: (2021-10-01)

Therapeutic Applications of the CRISPR-Cas System
by: Kyungmin Kang, et al.
Published: (2022-09-01)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01)

Editorial: Prevention of viral diseases by gene targeting
by: Fan Luo, et al.
Published: (2024-03-01)

Loss of flrt2 gene leads to microphthalmia in zebrafish
by: Siyu Yang, et al.
Published: (2023-06-01)

Not Only Editing: A Cas-Cade of CRISPR/Cas-Based Tools for Functional Genomics in Plants and Animals
by: Aurélien Devillars, et al.
Published: (2024-03-01)

Applications of gene modification technologies in the treatment of inherited diseases
by: Maciej Superson, et al.
Published: (2024-04-01)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
by: Mujeeb ur Rahman, et al.
Published: (2022-06-01)

Gene therapy using genome‐edited iPS cells for targeting malignant glioma
by: Ryota Tamura, et al.
Published: (2023-09-01)

Gene editing therapy ready for cardiovascular diseases: opportunities, challenges, and perspectives
by: Zhou Jun, et al.
Published: (2021-10-01)

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
by: Virginie Mariot, et al.
Published: (2022-07-01)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
by: Deepak Kumar Sahel, et al.
Published: (2023-07-01)

Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
by: Tiffany Yee, et al.
Published: (2022-10-01)

Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
by: Khaled S. Allemailem, et al.
Published: (2023-04-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)

Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
by: Lifang Zhou, et al.
Published: (2023-04-01)

The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01)

Use of gene therapy for optic nerve protection: Current concepts
by: Kexin Xu, et al.
Published: (2023-04-01)

CRISPR Interference–Potential Application in Retinal Disease
by: Caroline F. Peddle, et al.
Published: (2020-03-01)

Off-target effects in CRISPR/Cas9 gene editing
by: Congting Guo, et al.
Published: (2023-03-01)

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
by: Saeed Rafii, et al.
Published: (2022-02-01)

Comparison of In-Frame Deletion, Homology-Directed Repair, and Prime Editing-Based Correction of Duchenne Muscular Dystrophy Mutations
by: Xiaoying Zhao, et al.
Published: (2023-05-01)

CRISPR delivery with extracellular vesicles: Promises and challenges
by: Anne Højberg Berggreen, et al.
Published: (2023-09-01)

Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
by: Meng Lin, et al.
Published: (2023-12-01)

CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements
by: Ali Nasrallah, et al.
Published: (2022-11-01)

Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology
by: Cláudia Carvalho, et al.
Published: (2023-09-01)

Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM
by: Yunxing Liu, et al.
Published: (2021-08-01)

Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms
by: Zifen Xu, et al.
Published: (2022-07-01)

NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms
by: Maram Ganaiem, et al.
Published: (2023-09-01)